云南白药 (000538.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(云南白药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 10,774,290,921.4939,111,292,156.0029,688,532,074.4420,309,372,850.0710,512,750,996.1436,488,372,649.7326,915,689,706.7818,016,738,609.159,429,539,929.02
 营业利润(元) 1,918,019,878.044,830,506,110.424,873,377,249.693,313,345,408.991,730,180,725.553,371,279,186.102,536,852,034.541,658,041,078.611,084,002,171.63
 利润总额(元) 1,919,694,290.704,818,011,756.664,863,763,288.093,303,279,659.051,727,153,106.103,377,002,423.702,536,721,708.201,656,659,787.721,083,819,062.48
 净利润(元) 1,699,046,405.004,122,561,096.494,122,506,023.562,826,258,821.441,515,723,471.892,840,409,694.192,140,233,274.901,366,409,793.62903,564,058.61
 归属于母公司股东的净利润(元) 1,701,931,446.004,093,782,074.024,123,477,414.452,828,011,615.301,517,988,356.563,001,125,887.452,304,896,295.311,500,494,603.81914,368,241.49
盈利能力:
 销售毛利率(%) 29.9826.5127.3727.5527.4226.3228.2129.0030.14
 销售净利率(%) 15.7710.5413.8913.9214.427.787.957.589.58
 净资产收益率(%) 4.1710.4510.617.483.83----
 总资产报酬率ROA(%) 3.328.518.906.283.15----
 投入资本回报率ROIC(%) 3.839.509.616.683.517.065.473.592.13
营运能力:
 存货周转率(次) 1.153.982.731.910.98----
 应收账款周转率(次) 1.014.103.342.331.17----
 总资产周转率(次) 0.190.730.570.400.19----
偿债能力:
 资产负债率(%) 26.8525.8025.2125.6726.8227.7526.6425.4725.68
 股东权益比率(%) 73.1174.1574.7974.3373.1472.2173.1974.2873.71
 已获利息倍数(倍) -27.56-17.58-24.43-30.17-61.20-8.85-10.97-9.12-8.75
 流动比率 2.772.852.882.802.732.632.722.822.84
 速动比率 2.302.312.272.192.161.991.972.052.08
发展能力:
 营业收入增长率(%) 2.497.1910.3012.7311.490.31-5.10-5.59-8.70
 营业利润增长率(%) 10.8643.2892.1099.8359.61-3.27-15.09-25.4323.01
 税后利润增长率(%) 12.1236.4178.9088.4766.027.00-5.94-16.7219.81
 净资产增长率(%) 3.873.575.444.132.230.72-0.290.090.38
 总资产增长率(%) 3.910.873.194.063.041.88-1.050.61-1.26

前瞻产业研究院